BrightSpec, a Charlottesville, VA-based life science tools company, raised $18.4M in Series C funding.
The round was led by Genoa Ventures and Arboretum Ventures, with participation from Medvest Capital, Felton Group LLC, and the UVA Seed Fund. Jenny Rooke, Ph.D., and Dan Kidle, from Genoaand Arboretum respectively, have joined BrightSpec’s Board of Directors.
The company intends to use the funds to expand its development efforts and its business reach.
Led by CEO Walter H. Colsman,
BrightSpec is commercializing MRR, a novel spectroscopic technique to rapidly and definitively characterize the unique 3-dimensional structure of small molecules, including all forms of structural, spatial, and isotopic isomers. MRR utilizes computational quantum chemistry to predict and validate a new structure, eliminating the need for any reference standards. BrightSpec offers an extensive database of calculated and validated structural spectra and tools for the rapid identification of unknown compounds in crude samples. High throughput analysis can be achieved without chromatography steps, providing quantitation directly out of a crude mixture in minutes. Paired with software solutions and minimal sample prep, customers can deploy targeted instruments outside of the analytical lab for rapid, routine analysis.
To date, the company has empowered customers with proven solutions across the pharmaceutical, consumer and beverage, and industrial chemical industries.
FinSMEs
15/12/2022